retatrutide type 2 diabetes trial results 2024 ๐จBreaking: Retatrutide's first Phase 3 T2D data just dropped. โธ A1C: โ2.0% at 40 weeks โธ Weight: โ36.6 lbs (โ16.8%) at 12 mg โธ No weight loss plateau โ curve still descending Perceived benefits of treatment for
Description
It reduced the fentanyl intake and their desire for the drug, without affecting their eating habits or causing negative side effects
Please reach out to the authors, your Foley relationship partner, or to our Health Care Practice Group and Health Care & Life Sciences Sector with any questions.
Weight Loss: One of the most compelling benefits of GLP-1 therapy is its ability to promote weight loss
Is retatrutide better than tirzepatide for research
Stomach Troubles Many users feel nausea, vomiting, abdominal pain, or have acid reflux (a burning feeling in the chest)
